The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

Abroad (travel likely)RecruitingPHASE1

Conditions

Cannabis Use

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
Contact: Study coordinator (Tory Spindle, PhD) · tspindle@jhmi.edu · 410-550-0529

Study leads

Tory Spindle, PhD
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effect of Cannabis on E-Cigarette Use Behavior

Cannabis Use · Tobacco Use · Electronic Cigarette Use

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

Cannabinoids and Biological Reactivity to Stress

Cannabis Use Disorder

Abroad (travel likely)RecruitingEARLY_PHASE1

Tallahassee, United States

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Bipolar Disorder · Cannabis Use · Schizoaffective Disorder, Bipolar Type

Abroad (travel likely)RecruitingPHASE2

Charleston, United States

Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment

Cannabis Use · Risk Perception · Decision Making

Abroad (travel likely)Recruiting

Oklahoma City, United States